CIS PLATIN:

                    Cisplatin, also known as cis-diamminedichloroplatinum(II), is a chemotherapy drug widely used in the treatment of various cancers, including testicular, ovarian, bladder, and lung cancers. Its discovery and development as an anticancer agent is a fascinating story, blending serendipity, scientific curiosity, and innovation.

 Discovery and Development:

 Initial Discovery (1965):The history of cisplatin began in the 1960s when a scientist named Barnett Rosenberg, working at Michigan State University, made an accidental discovery. Rosenberg and his colleagues were researching the effects of electric fields on bacteria. They used platinum electrodes in their experiment and noticed that bacteria exposed to the platinum-containing solution stopped dividing. The compound was a platinum-based molecule, which led to further investigation into its potential as an anticancer agent.

Research and Identification of Cisplatin (1969):After Rosenberg's initial discovery, further studies revealed that the compound responsible for inhibiting bacterial division was cisplatin. This molecule, which contains a platinum atom surrounded by two chloride ions and two ammine (NH₃) groups, was identified as a promising candidate for cancer treatment. Researchers recognized that platinum compounds could disrupt DNA function in cells, potentially inhibiting cancer cell replication.

Preclinical Trials and Approval (1970s):In the early 1970s, Rosenberg and his team conducted experiments on mice and found that cisplatin showed potential in shrinking tumors, specifically in testicular cancer. The compound's anticancer effects were profound enough to warrant further clinical investigations. It was eventually tested in humans, showing significant activity against various types of cancer, particularly testicular cancer.

Clinical Trials and FDA Approval (1978-1980):After successful preclinical trials, cisplatin moved into clinical trials in the 1970s. The drug was found to be especially effective in the treatment of testicular cancer, a disease that was once nearly always fatal but could now be cured with cisplatin-based regimens. In 1978, the drug was approved by the U.S. Food and Drug Administration (FDA) for use in patients with testicular cancer. Cisplatin's success in treating testicular cancer was followed by its use for other types of cancer, including ovarian, bladder, and lung cancers.

Mechanism of Action:

Cisplatin works by binding to DNA in cancer cells, causing DNA crosslinking and disrupting DNA replication. This process damages the cancer cell's ability to divide, which ultimately leads to cell death. This action, however, is not entirely specific to cancer cells, and cisplatin can also affect normal cells, leading to side effects like nephrotoxicity (kidney damage), neurotoxicity, and ototoxicity (hearing loss). Despite these side effects, cisplatin remains one of the most effective chemotherapy agents in the treatment of several cancers.

Evolution and Derivatives: While cisplatin was revolutionary, its side effects, particularly kidney toxicity, led to the development of derivatives like carboplatin, which has a similar mechanism of action but is somewhat less toxic, particularly to the kidneys. Carboplatin became another key drug used in chemotherapy regimens.





Oxaliplatin: Another platinum-based chemotherapy drug, oxaliplatin, was developed later and is commonly used in the treatment of colorectal cancer. It, too, is part of the platinum compound family and has a slightly different side effect profile.




Resistance and Ongoing Research: A major challenge with cisplatin and other platinum-based chemotherapy drugs is the development of resistance in cancer cells. Over time, cancer cells can become less sensitive to cisplatin, often due to changes in cellular mechanisms that prevent the drug from effectively damaging DNA. This has led to continuous research into ways to overcome or prevent resistance and to develop new platinum-based drugs with enhanced efficacy and reduced toxicity.

Legacy:

Today, cisplatin is still one of the cornerstone drugs in chemotherapy and has saved countless lives since its discovery. It is often used in combination with other drugs to treat a variety of cancers. Its impact on cancer therapy is immense, and it continues to be studied as part of ongoing efforts to improve treatment outcomes and reduce side effects.

CONTACT @ chemicalscientists@gmail.com

WEBSITE:https://chemicalscientists.com/

SOCIAL MEDIA LINKS:youtube:https://www.youtube.com/channel/UCjwytKx-vie23L7RlNsYhBg

pinterest:https://in.pinterest.com/chemicalscientists/
Linkedin:https://www.linkedin.com/in/chemicalscientists-elemental-meetup-743568348/

Comments

Popular posts from this blog